Mutares has closed its acquisition of Magna’s European lighting business through portfolio company Amaneos, adding roughly €200 million in annual sales and 1,500 employees to the holding group. The transaction brings four European sites — two production plants in Moncalieri, Italy, and Kostrzyn nad Odrą, Poland, along with development centers in Rivoli, Italy, and Ostrava, Czech Republic — and covers front and rear lighting, accent lighting, and illuminated grilles built on LED, OLED, and matrix technology.
The deal marks a deliberate step up the value chain for Amaneos, whose existing LMS subsidiary chiefly manufactures exterior vehicle panels. By combining bodywork and lighting into pre-assembled modules, the unit aims to simplify procurement for automakers while carving out more design flexibility. Mutares expects research, purchasing and manufacturing synergies to accelerate innovation and eventually lift Amaneos’s margins.
Yet the market has barely reacted. Shares closed at €28.30 on Wednesday, down 1.22% over the past week and 5.35% since the start of 2026. The 12-month decline of 18.21% leaves the stock trading nearly 20% below its 52-week high of €35.15 hit in mid-January, and about 21% above the year’s low of €23.30 touched in late April. The 200-day moving average sits at €28.93, with the current price 2.34% below that line, while the relative strength index hovers at a neutral 50.6 — a reading that offers no directional bias.
Management and the supervisory board have proposed a €2.00 per share dividend for fiscal 2025, which Mutares describes as a minimum payout. A second, performance-linked distribution would only be considered once future exits deliver meaningful contributions to earnings and liquidity. Whether that happens depends on completing the kind of portfolio sales that remain hard to schedule in a holding model — a risk that has weighed on investor sentiment all year.
Should investors sell immediately? Or is it worth buying Mutares?
On the positive side, Mutares completed a €105 million capital raise in April to bankroll an accelerated push into the United States. The acquisition pipeline in North America now contains opportunities with a combined revenue base of roughly €4.8 billion, and a second U.S. office is planned in addition to the existing Chicago location. Regulatory relief came earlier when BaFin closed its review of the 2023 annual accounts without material objections.
But the balance sheet tells a more cautious story. Mutares has committed to significantly reducing its leverage, a pledge that consumes cash flow and leaves little room for slippage. The company’s 2026 revenue target of €7.9 billion to €9.1 billion and net income guidance of €165 million to €200 million hinge on closing announced exit processes — exactly the sort of event risk that has kept the stock volatile. The 30-day annualized volatility stands at 27.44%, and the RSI of 50.2 (on a slightly different calculation from the previous reading) confirms the indecision.
For now, the €2.00 dividend provides a floor to shareholder returns, and the US expansion is funded through the recent equity injection. But the 18.35% drop over twelve months shows how deeply the market discounts the uncertainty around future disposal proceeds. If the planned exits for 2026 materialize as hoped, the performance dividend could come back into play; if not, attention will shift to debt metrics and the achievability of the full-year forecast. The first concrete test arrives with the half-year results, expected in the third quarter of 2026, which should offer the earliest clues on whether the exit and earnings targets remain within reach.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from July 2 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 2.
Mutares: Buy or sell? Read more here...
